Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dehydroepiandrosterone sulphate in critical illness: effect of dopamine.
Van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1995 Oct;43(4):457-63. doi: 10.1111/j.1365-2265.1995.tb02618.x. Clin Endocrinol (Oxf). 1995. PMID: 7586621 Clinical Trial.
Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1996 Sep;45(3):341-51. doi: 10.1046/j.1365-2265.1996.00805.x. Clin Endocrinol (Oxf). 1996. PMID: 8949573 Clinical Trial.
The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY. Van den Berghe G, et al. J Clin Endocrinol Metab. 1997 Feb;82(2):590-9. doi: 10.1210/jcem.82.2.3736. J Clin Endocrinol Metab. 1997. PMID: 9024260 Clinical Trial.
Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.
Van den Berghe G, de Zegher F, Baxter RC, Veldhuis JD, Wouters P, Schetz M, Verwaest C, Van der Vorst E, Lauwers P, Bouillon R, Bowers CY. Van den Berghe G, et al. J Clin Endocrinol Metab. 1998 Feb;83(2):309-19. doi: 10.1210/jcem.83.2.4575. J Clin Endocrinol Metab. 1998. PMID: 9467533 Clinical Trial.
Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.
Van den Berghe G, Wouters P, Bowers CY, de Zegher F, Bouillon R, Veldhuis JD. Van den Berghe G, et al. Eur J Endocrinol. 1999 Jan;140(1):17-22. doi: 10.1530/eje.0.1400017. Eur J Endocrinol. 1999. PMID: 10037246 Clinical Trial.
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness.
Van den Berghe G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD, Bowers CY, Bouillon R. Van den Berghe G, et al. J Clin Endocrinol Metab. 1999 Apr;84(4):1311-23. doi: 10.1210/jcem.84.4.5636. J Clin Endocrinol Metab. 1999. PMID: 10199772 Clinical Trial.
A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Veldhuis JD. Van den Berghe G, et al. J Clin Endocrinol Metab. 2000 Jan;85(1):183-92. doi: 10.1210/jcem.85.1.6316. J Clin Endocrinol Metab. 2000. PMID: 10634385 Clinical Trial.
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD. van den Berghe G, et al. J Clin Endocrinol Metab. 2001 Jul;86(7):3217-26. doi: 10.1210/jcem.86.7.7680. J Clin Endocrinol Metab. 2001. PMID: 11443192 Clinical Trial.
Intensive insulin therapy in critically ill patients.
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. van den Berghe G, et al. N Engl J Med. 2001 Nov 8;345(19):1359-67. doi: 10.1056/NEJMoa011300. N Engl J Med. 2001. PMID: 11794168 Clinical Trial.
80 results
Jump to page
Feedback